BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8650693)

  • 41. Antagonistic anticancer effect of paclitaxel and digoxin combination.
    Pereira DG; Rendeiro MM; Cortes VF; Barbosa LA; Quintas LEM
    J Cell Biochem; 2019 Aug; 120(8):13107-13114. PubMed ID: 30883884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of rat brain microsomal Na+/K(+)-ATPase and ouabain binding by mercuric chloride.
    Chetty CS; Rajanna B; Rajanna S
    Toxicol Lett; 1990 Mar; 51(1):109-16. PubMed ID: 2156358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats.
    Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK
    Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further evidence for the dissociation of digoxin-like immunoreactivity from Na+,K(+)-ATPase inhibitory activity.
    Yamada K; Goto A; Ishii M; Yoshioka M; Sugimoto T
    Experientia; 1990 Oct; 46(10):1041-3. PubMed ID: 2171976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Na, K-ATPase activity of the microsomal fraction of the rat brain exposed to insulin].
    Komissarenko VP; Efimova EK
    Biull Eksp Biol Med; 1985 Jan; 99(1):31-3. PubMed ID: 2981575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The stimulatory effect on human erythrocyte rubidium-86 uptake by anti-cardiac-glycoside antibodies.
    Balzan S; Montali U; Pieraccini L; Di Bartolo V; Pegoraro S; Revoltella R; Ghione S
    Q J Nucl Med; 1995 Jun; 39(2):134-9. PubMed ID: 8574808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformational changes of membrane-bound (Na+-K+)-ATPase as revealed by antibody inhibition.
    Koepsell H
    J Membr Biol; 1979 Mar; 45(1-2):1-20. PubMed ID: 87516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sensitivity of rat brain Na+,K+-ATPase catalytic subunit isoforms to Ds-Na].
    Kaplia AA; Kravtsov AV; Kravtsova VV
    Biokhimiia; 1995 Jun; 60(6):970-5. PubMed ID: 7654867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin interacts directly with Na⁺/K⁺ATPase and protects from digoxin toxicity.
    Oubaassine R; Weckering M; Kessler L; Breidert M; Roegel JC; Eftekhari P
    Toxicology; 2012 Sep; 299(1):1-9. PubMed ID: 22562035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selectivity analyses of γ-benzylidene digoxin derivatives to different Na,K-ATPase α isoforms: a molecular docking approach.
    Pessôa MTC; Alves SLG; Taranto AG; Villar JAFP; Blanco G; Barbosa LA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):85-97. PubMed ID: 29115894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute effects of digoxin on plasma aldosterone and cortisol in monkeys.
    Kau MM; Kan SF; Wang JR; Wang PS; Lau YT; Wang SW
    Metabolism; 2009 Jan; 58(1):55-61. PubMed ID: 19059531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of endogenous Na+,K+-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography.
    Crabos M; Wainer IW; Cloix JF
    FEBS Lett; 1984 Oct; 176(1):223-8. PubMed ID: 6208054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digoxin antibody prevents cerebral hemorrhage-induced hypertension.
    Menezes JC; Dichtchekenian V
    Am J Hypertens; 2003 Dec; 16(12):1062-5. PubMed ID: 14643583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High affinity anti-digoxin antibodies as model receptors for cardiac glycosides. Comparisons with Na+,K(+)-ATPase.
    Kasturi R; McLean LR; Margolies MN; Ball WJ
    Ann N Y Acad Sci; 1997 Nov; 834():634-6. PubMed ID: 9405877
    [No Abstract]   [Full Text] [Related]  

  • 57. The γ-Benzylidene Digoxin Derivative BD-15 Increases the α3-Na, K-ATPase Activity in Rat Hippocampus and Prefrontal Cortex and no Change on Heart.
    Parreira GM; Faria JA; Marques SMS; Garcia IJP; Silva IF; De Carvalho LED; Villar JAFP; Machado MV; de Castro Lima M; Barbosa LA; Cortes VF; de Lima Santos H
    J Membr Biol; 2021 Apr; 254(2):189-199. PubMed ID: 33598793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Endogenous activators and inhibitors of Na, K-ATPase induced by acetylcholine].
    Elaev NR; Andreev VP; Shavrina NV
    Biull Eksp Biol Med; 1983 Feb; 95(2):40-2. PubMed ID: 6297634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
    Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
    Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digoxin and membrane sodium potassium ATPase inhibition in cardiovascular disease.
    Ravi Kumar A; Kurup PA
    Indian Heart J; 2000; 52(3):315-8. PubMed ID: 10976153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.